Spotlight on Apoptosis
|
Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies
|
1
|
AM Senderowicz
|
Abstract Full Article PDF
|
 |
|
Editorial
|
Hypothesis: Phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia
|
10
|
TA McDonald, NT Holland, C Skibola, P Duramad & MT Smith
|
Abstract Full Article PDF
|
 |
|
Reviews
|
Molecular signals in anti-apoptotic survival pathways
|
21
|
DM O'Gorman & TG Cotter
|
Abstract Full Article PDF
|
 |
Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study
|
35
|
MA Elliott, GW Dewald, A Tefferi & CA Hanson
|
Abstract Full Article PDF
|
 |
|
Original Manuscripts
|
Second malignancy after treatment of childhood acute myeloid leukemia
|
41
|
W Leung, RC Ribeiro, M Hudson, X Tong, DK Srivastava, JE Rubnitz, JT Sandlund, BI Razzouk, WE Evans & C-H Pui
|
Abstract Full Article PDF
|
 |
Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia
|
46
|
MM Bisschop, T Révész, M Bierings, JF van Weerden, ER van Wering, K Hählen & A van der Does-van den Berg
|
Abstract Full Article PDF
|
 |
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions
|
50
|
A Balduzzi, G Gaipa, S Bonanomi, M Dassi, P Perseghin, F Buscemi, E D'Aniello, A Rovelli, R Schirò, D Longoni, A Rambaldi, C Uderzo & A Biondi
|
Abstract Full Article PDF
|
 |
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing
|
57
|
JE Sarriera, M Albitar, Z Estrov, C Gidel, R Aboul-Nasr, T Manshouri, S Kornblau, K-S Chang, H Kantarjian & E Estey
|
Abstract Full Article PDF
|
 |
Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia
|
62
|
A Krämer, H Löffler, J Bergmann, A Hochhaus & R Hehlmann
|
Abstract Full Article PDF
|
 |
Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells
|
69
|
M Ahlmann, C Lanvers, K Lümkemann, C Rössig, A Freund, M Baumann & J Boos
|
Abstract Full Article PDF
|
 |
6-Mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia
|
74
|
K Schmiegelow & U Bretton-Meyer
|
Abstract Full Article PDF
|
 |
Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance
|
80
|
M Smeets, R Raymakers, P Muus, G Vierwinden, P Linssen, R Masereeuw & T de Witte
|
Abstract Full Article PDF
|
 |
Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
|
89
|
I Kitabayashi, Y Aikawa, A Yokoyama, F Hosoda, M Nagai, N Kakazu, T Abe & M Ohki
|
Abstract Full Article PDF
|
 |
Detection of E2A translocations in leukemias via fluorescence in situ hybridization
|
95
|
T Boomer, M Varella-Garcia, L McGavran, L Meltesen, AS Olsen & SP Hunger
|
Abstract Full Article PDF
|
 |
C/EBP -/- mice: increased rate of myeloid proliferation and apoptosis
|
103
|
W Verbeek, M Wächter, J Lekstrom-Himes & HP Koeffler
|
Abstract Full Article PDF
|
 |
The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro
|
112
|
S Horn, J Meyer, J Heukeshoven, B Fehse, C Schulze, S Li, J Frey, S Poll, C Stocking & M Jücker
|
Abstract Full Article PDF
|
 |
Immunoglobulin lambda isotype gene rearrangements in B cell malignancies
|
121
|
T Tümkaya, M van der Burg, R Garcia Sanz, M Gonzalez Diaz, AW Langerak, JF San Miguel & JJM van Dongen
|
Abstract Full Article PDF
|
 |
HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse
|
128
|
M Wetzler, MR Baer, SJ Stewart, K Donohue, L Ford, CC Stewart, EA Repasky & S Ferrone
|
Abstract Full Article PDF
|
 |
Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy
|
134
|
V de Haas, OJHM Verhagen, AEGKr von dem Borne, W Kroes, H van den Berg & CE van der Schoot
|
Abstract Full Article PDF
|
 |
Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice
|
141
|
DS Chervinsky, DH Lam, X-F Zhao, MP Melman & PD Aplan
|
Abstract Full Article PDF
|
 |
Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK
|
148
|
Y Kagami, J Jung, YS Choi, K Osumi, S Nakamura, Y Morishima & M Seto
|
Abstract Full Article PDF
|
 |
Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia
|
157
|
T Uchida, T Kinoshita, T Ohno, H Ohashi, H Nagai & H Saito
|
Abstract Full Article PDF
|
 |
|
Bio-technical Methods Section (BTS)
|
Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay
|
166
|
X Chen, Q Pan, P Stow, FG Behm, R Goorha, C-H Pui & GAM Neale
|
Abstract Full Article PDF
|
 |
Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinicalbiological features
|
171
|
M Dominici, D Campioni, F Lanza, M Luppi, P Barozzi, S Pauli, R Milani, F Cavazzini, M Punturieri, R Trovato, G Torelli & G Castoldi
|
Abstract Full Article PDF
|
 |
Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis
|
177
|
A Viardot, JI Martin-Subero, R Siebert, S Harder, S Gesk, M Bentz & B Schlegelberger
|
Abstract Full Article PDF
|
 |
|
Correspondence
|
The natural history and clinico-pathological features of the variant form of hairy cell leukemia
|
184
|
E Matutes, A Wotherspoon, V Brito-Babapulle & D Catovsky
|
Full Article PDF
|
 |
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion
|
186
|
C Rigamonti, C Volta, S Colombi, L Forti, F Savinelli, G Gaidano & E Bartoli
|
Full Article PDF
|
 |
Remission of severe cold agglutinin disease Rituximab therapy
|
187
|
N Layios, E Van Den Neste, E Jost, V Deneys, JM Scheiff & A Ferrant
|
Full Article PDF
|
 |
Age cohort subgroups in adult acute myeloid leukaemia studies - the population perspective
|
188
|
SJ Proctor & PRA Taylor
|
Full Article PDF
|
 |
CD13/aminopeptidase N involvement in dendritic cell maturation
|
190
|
VHJ van der Velden, PJM Leenen & HA Drexhage
|
Full Article PDF
|
 |
Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16: expression of MRP1 homologues
|
191
|
DM van der Kolk, EGE de Vries & E Vellenga
|
Full Article PDF
|
 |
Is HLA-DR4 or the HLA-DRB1*0402 allele associated with decreased risk for CML?
|
192
|
G Pawelec & W Wagner
|
Full Article PDF
|
 |
 |
 |